Home
Integrated Core Strategies reported a 7.2% stake in Quince Therapeutics QNCX · 1,403,697 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 7.2%
- Last report
- First report
- Shares held
- 1,403,697 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 26/06/04
- Filed
- 26/06/10
First 5%+ report · 7.2% stake
Quince Therapeutics trades, last 26 weeks
What else happened in Quince Therapeutics around then
Filed or reported within 30 days of the trade day · 05/05~07/04Integrated Core Strategies's other 5% stake reports
- Integrated Core Strategies
5% stakeBetter Home & Finance Holding
5% stakeBetter Home & Finance Holding
BETR
5.5% stake
730,265 sh
5.5% stake
Filed 09/22
- Integrated Core Strategies
5% stakeKaryopharm Therapeutics
5% stakeKaryopharm Therapeutics
KPTI
5.7% stake
1,297,297 sh
5.7% stake
Filed 09/04
- Integrated Core Strategies
5% stakeFortress Biotech
5% stakeFortress Biotech
FBIO
5.3% stake
1,778,561 sh
5.3% stake
Filed 09/01
- Integrated Core Strategies
5% stakeTenaya Therapeutics
5% stakeTenaya Therapeutics
TNYA
5.2% stake
11,581,565 sh
5.2% stake
Filed 08/24
- Integrated Core Strategies
5% stakeCollegium Pharmaceutical
5% stakeCollegium Pharmaceutical
COLL
5.6% stake
1,820,330 sh
5.6% stake
Filed 08/24
